10 Best Stocks Near All-Time Highs to Buy According to Wall Street
A record share price can feel like a warning that the easy money has already been made. Historical market evidence gives that instinct a more complicated answer. J.P.
Guardant Health Inc. (GH)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 3,393,312 | $509,098,599 | +2% | 7.41% |
| 2. | 104,512,000 | $263,108,283 | +9% | 0.13% | |
| 3. | Millennium Management Israel Englander | 1,622,458 | $243,417,374 | +77% | 0.09% |
| 4. | Driehaus Capital Richard Driehaus | 1,533,985 | $230,143,770 | +1% | 1.33% |
| 5. | Citadel Investment Group Ken Griffin | 1,449,534 | $217,473,586 | +87% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $130.76 | 600 | $78,456.00 | 41,414 | 2026-06-15 | Filing | |
| $17.82 | 2,187 | $38,962.72 | 12,722 | 2024-03-18 | Filing | |
| $32.78 | 750 | $24,584.25 | 5,193 | 2023-06-09 | Filing | |
| $32.68 | 2,231 | $72,913.77 | 4,443 | 2023-06-09 | Filing | |
| $26.15 | 8,600 | $224,927.84 | 2,049,238 | 2023-03-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $178.00 | 7,738 | $1,377,364.00 | 70,635 | 2026-09-15 | Filing | |
| $177.48 | 971 | $172,329.78 | 7,906 | 2026-09-16 | Filing | |
| $176.34 | 1,300 | $229,236.02 | 8,877 | 2026-09-16 | Filing | |
| $175.42 | 3,300 | $578,887.98 | 10,177 | 2026-09-16 | Filing | |
| $174.46 | 1,103 | $192,431.92 | 13,477 | 2026-09-16 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,218 | $2,179,190 | 0.82% | |
| 2. | 6,118 | $1,091,186 | 0.66% | |
| 3. | 3,756 | $669,921 | 0.01% | |
| 4. | 3,710 | $661,716 | 0.07% | |
| 5. | 1,174 | $209,395 | 0.04% |
News See All
What Makes Guardant Health (GH) a Compelling Bet?
Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. The letter can be downloaded here.
Guardant Health Faces a $245 Million Patent Judgment, But Its Newer Tests Could Offer Protection
Guardant Health, Inc. (NASDAQ:GH) faces a costly legal setback after a US court ordered the cancer-testing company to pay more than $245.2 million in a DNA-sequencing patent dispute.
Guardant Health (GH) Surges on FDA Approval and Cancer Screening Momentum
Aristotle Capital Management, LLC, an investment management company, released its "Core Equity Fund" Q2 2026 investor letter. A copy of the letter can be downloaded here.
Guardant Health (GH) Sees 48% Growth as Its Cancer Tests Gain Momentum
Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.
Strong Results Boosted Guardant Health (GH) in Q2
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here. U.S.
10 Best Large Cap Stocks to Buy Under $100
In this article, we will discuss the 10 Best Large Cap Stocks to Buy Under $100.
10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen
In this article, we will discuss: 10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen.
Guardant Health, Inc. (NASDAQ:GH) Q1 2026 Earnings Call Transcript
Guardant Health, Inc. (NASDAQ:GH) Q1 2026 Earnings Call Transcript May 7, 2026Guardant Health, Inc. misses on earnings expectations. Reported EPS is $-0.85 EPS, expectations were $-0.47.
Does Guardant Health (GH) Have Long-Runway for Growth?
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.
Hedge Fund Resource Center